Executives On The Move: Departures and Arrivals at Endologix, Gilead Sciences and Perrigo
Executive Summary
Endologix CEO makes a switch to CEO at Vascular Therapies, and Clinical Research and Commercial VPs exit Gilead Sciences. Plus, producer of OTC and generic drugs Perrigo Company appoints EVP, CSO.